Botanix Pharmaceuticals Limited
BXPHF
$0.25
$0.000.00%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.77% | -77.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.77% | -77.31% | |||
| Cost of Revenue | -2.74% | -54.05% | |||
| Gross Profit | 2.73% | 13.99% | |||
| SG&A Expenses | -2.75% | 335.23% | |||
| Depreciation & Amortization | -2.75% | 1,675.36% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.75% | 223.83% | |||
| Operating Income | 2.75% | -283.99% | |||
| Income Before Tax | 2.75% | -273.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.75% | -273.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.75% | -273.77% | |||
| EBIT | 2.75% | -283.99% | |||
| EBITDA | 2.75% | -273.40% | |||
| EPS Basic | 3.51% | -216.67% | |||
| Normalized Basic EPS | 2.78% | -227.27% | |||
| EPS Diluted | 3.51% | -216.67% | |||
| Normalized Diluted EPS | 2.78% | -227.27% | |||
| Average Basic Shares Outstanding | 0.00% | 16.14% | |||
| Average Diluted Shares Outstanding | 0.00% | 16.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
